Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001213900-17-006882)

Filing Details

Accession Number:: 0001213900-17-006882
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-06-28 11:31:49
Reporting Period:: 2017-06-26

Filing Date:: 2017-06-28
Accepted Time:: 2017-06-28 11:31:49
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1498382	Delmar Pharmaceuticals Inc.	DMPI	Pharmaceutical Preparations (2834)	990360497

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1633660	Sarah Lynda Cranston	Suite 720-999 West Broadway Vancouver A1 V5Z 1K5		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-06-26	2,083	$3.60	2,344	No	4	P	Indirect	Note

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	Note

Footnotes

The Reporting Person purchased the shares in a private transaction for an aggregate purchase price of CDN $10,000. Reported price is based on exchange rate of 0.75.
Shares are held by J.G. Cranston & Associates, Inc.